Removing barriers to treatment of first-episode psychotic disorders

被引:23
|
作者
Scholten, DJ
Malla, AK
Norman, RMG
McLean, TS
McIntosh, EM
McDonald, CL
Eliasziw, M
Speechley, KN
机构
[1] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada
[2] Univ Western Ontario, Dept Psychiat, London, ON, Canada
[3] Douglas Hosp, Res Ctr, Div Clin Res, Montreal, PQ, Canada
[4] McGill Univ, Dept Psychiat, Montreal, PQ, Canada
[5] Lawson Hlth Res Inst, London, ON, Canada
[6] Douglas Hosp, Res Ctr, PEPP Montreal, Montreal, PQ, Canada
[7] London Hlth Sci Ctr, London, ON, Canada
[8] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[9] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
[10] Univ Western Ontario, Dept Pediat, London, ON N6A 3K7, Canada
[11] Child Hlth Res Inst, London, ON, Canada
关键词
early intervention; psychosis; schizophrenia; duration of untreated psychosis; DUP; source of referral; barriers to care;
D O I
10.1177/070674370304800808
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To describe changes aimed at removing barriers to appropriate and timely assessment and treatment of first-episode psychosis (FEP) and to present descriptive data regarding the potential impact of such changes on treated incidence, referral patterns, and treatment delay. Method: We collected demographic and clinical information, including duration of untreated psychosis (DUP), on 196 persons referred for an initial assessment over a 3-year period. Results: The number of identified FEP cases increased and DUP decreased over the 3-year period. The data suggest a differentially greater reduction in DUP in cases referred from sources other than health care. Conclusion: These preliminary results suggest that, when setting up programs for FEP, relatively simple changes designed to improve access may improve treated incidence and reduce treatment delays.
引用
收藏
页码:561 / 565
页数:5
相关论文
共 50 条
  • [41] Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders
    Albus, M
    Hubmann, W
    Wahlheim, C
    Sobizack, N
    Franz, U
    Mohr, F
    ACTA PSYCHIATRICA SCANDINAVICA, 1996, 94 (02) : 87 - 93
  • [42] Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders -: A systematic critical reappraisal
    Alvarez-Jimenez, Mario
    Gonzalez-Blanch, Cesar
    Crespo-Facorro, Benedicto
    Hetrick, Sarah
    Rodriguez-Sanchez, Jose Manuel
    Perez-Iglesias, Rocio
    Vazquez-Barquero, Jose Luis
    CNS DRUGS, 2008, 22 (07) : 547 - 562
  • [43] Cognitive-behavioural Case Management in First-Episode Schizophrenia and Related Psychotic Disorders - The Portuguese Experience
    Santos, L.
    Gago, J.
    Levy, P.
    Mateus, P.
    Robalo, P.
    Ferreira, R.
    Fonseca, A.
    Garrett, F.
    Baiao, H.
    EARLY INTERVENTION IN PSYCHIATRY, 2008, 2 : A21 - A21
  • [44] Longitudinal course of core cognitive domains in first-episode acute and transient psychotic disorders compared with schizophrenia
    Knizkova, Karolina
    Kerkova, Barbora
    Vecerova, Monika
    Sustova, Petra
    Jonas, Juraj
    Sironova, Aneta
    Hruby, Ales
    Rodriguez, Mabel
    SCHIZOPHRENIA RESEARCH-COGNITION, 2024, 37
  • [45] Neuropsychological dysfunction in anti psychotic-naive first-episode unipolar psychotic depression
    Hill, SK
    Keshavan, MS
    Thase, ME
    Sweeney, JA
    AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (06): : 996 - 1003
  • [46] Three-year clinical and functional outcome comparison between first-episode mania with psychotic features and first-episode schizophrenia
    Chang, Wing Chung
    Lau, Emily Sin Kei
    Chiu, Shirley Sanyin
    Hui, Christy Lai Ming
    Chan, Sherry Kit Wa
    Lee, Edwin Ho Ming
    Chen, Eric Yu Hai
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 200 : 1 - 5
  • [47] Electrodermal activation in first-episode psychotic patients and their first-degree relatives
    Iacono, WG
    Ficken, JW
    Beiser, M
    PSYCHIATRY RESEARCH, 1999, 88 (01) : 25 - 39
  • [49] The neurobiology and treatment of first-episode schizophrenia
    R S Kahn
    I E Sommer
    Molecular Psychiatry, 2015, 20 : 84 - 97
  • [50] The neurobiology and treatment of first-episode schizophrenia
    Kahn, R. S.
    Sommer, I. E.
    MOLECULAR PSYCHIATRY, 2015, 20 (01) : 84 - 97